Haoxi Health Technology Secures $5 Million in Private Placement

An update from Haoxi Health Technology Limited Class A ( (HAO) ) is now available.

On November 26, 2025, Haoxi Health Technology Limited entered into a Securities Purchase Agreement with several non-U.S. investors for a private placement of 6,250,000 Class A ordinary shares and 12,500,000 warrants, raising gross proceeds of $5 million. The closing of this offering occurred on December 3, 2025, with the funds intended for working capital and general corporate purposes. This strategic move is expected to strengthen the company’s financial position and support its operational growth, potentially enhancing its market presence and providing benefits to its stakeholders.

The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.

Spark’s Take on HAO Stock

According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.

The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.

To see Spark’s full report on HAO stock, click here.

More about Haoxi Health Technology Limited Class A

Haoxi Health Technology Limited operates in the health technology sector, focusing on innovative health solutions. The company is based in Beijing, China, and engages in the development and distribution of health-related products and services.

Average Trading Volume: 474,206

Technical Sentiment Signal: Sell

Current Market Cap: $3.07M

Find detailed analytics on HAO stock on TipRanks’ Stock Analysis page.